siRNA target site secondary structure predictions using local stable substructures.
The crystal structure based model of the catalytic center of Ago2 revealed that the siRNA and the mRNA must be able to form an A-helix for correct positing of the scissile phosphate bond for cleavage in RNAi. This suggests that base pairing of the target mRNA with itself, i.e. secondary structure, must be removed before cleavage. Early on in the siRNA design, GC-rich target sites were avoided because of their potential to be involved in strong secondary structure. It is still unclear how important a factor mRNA secondary structure is in RNAi. However, it has been established that a difference in the thermostability of the ends of an siRNA duplex dictate which strand is loaded into the RNA-induced silencing complex. Here, we use a novel secondary structure prediction method and duplex-end differential calculations to investigate the importance of a secondary structure in the siRNA design. We found that the differential duplex-end stabilities alone account for functional prediction of 60% of the 80 siRNA sites examined, and that secondary structure predictions improve the prediction of site efficacy. A total of 80% of the non-functional sites can be eliminated using secondary structure predictions and duplex-end differential.
Heale
Bret S E
BS
Graduate School of Biological Sciences, Beckman Research Institute of the City of Hope Duarte, CA 91010, USA.
Soifer
Harris S
HS
Bowers
Chauncey
C
Rossi
John J
JJ
D000465:Algorithms; D001483:Base Sequence; D009690:Nucleic Acid Conformation; D012333:RNA, Messenger / Q000737:chemistry*; D034741:RNA, Small Interfering / Q000737:chemistry*; D012367:RNA, Viral / Q000737:chemistry
D012333:RNA, Messenger; D034741:RNA, Small Interfering; D012367:RNA, Viral
Curr Biol. 2002 Dec 23;12(24):R852-4
12498706
Methods. 2002 Feb;26(2):199-213
12054897
J Biol Chem. 2003 Feb 28;278(9):7108-18
12500975
J Biol Chem. 2003 May 2;278(18):15991-7
12604614
Antisense Nucleic Acid Drug Dev. 2003 Apr;13(2):83-105
12804036
Nucleic Acids Res. 2003 Jul 1;31(13):3406-15
12824337
RNA. 2003 Sep;9(9):1034-48
12923253
Antisense Nucleic Acid Drug Dev. 2003;13(3):151-5
12954115
Cell. 2003 Oct 17;115(2):199-208
14567917
Cell. 2003 Oct 17;115(2):209-16
14567918
Nat Struct Biol. 2003 Dec;10(12):1026-32
14625589
Nature. 2003 Nov 27;426(6965):465-9
14615801
Nature. 2003 Nov 27;426(6965):468-74
14615802
EMBO Rep. 2004 Feb;5(2):189-94
14749716
Nucleic Acids Res. 2004;32(3):936-48
14769950
Nat Biotechnol. 2004 Mar;22(3):326-30
14758366
Nat Biotechnol. 2004 Mar;22(3):321-5
14990954
Methods Mol Biol. 2004;252:509-14
15017076
RNA. 2004 Apr;10(4):622-33
15037772
Biochem Biophys Res Commun. 2004 Apr 16;316(4):1050-8
15044091
Biochem Biophys Res Commun. 2004 May 21;318(1):303-10
15110788
Genes Dev. 2004 May 1;18(9):975-80
15105377
Nature. 2004 May 20;429(6989):318-22
15152257
Nat Struct Mol Biol. 2004 Jun;11(6):576-7
15156196
Nucleic Acids Res. 2004 Jul 1;32(Web Server issue):W135-41
15215366
Nat Struct Mol Biol. 2004 Jul;11(7):599-606
15170178
Science. 2004 Sep 3;305(5689):1434-7
15284453
Science. 2004 Sep 3;305(5689):1437-41
15284456
Cell. 1987 Feb 27;48(4):691-701
3643816
J Biomol Struct Dyn. 1985 Feb;2(5):953-62
2477031
Biopolymers. 1990 May-Jun;29(6-7):1105-19
1695107
Nucleic Acids Res. 1992 Jan 11;20(1):27-31
1738599
Comput Appl Biosci. 1992 Aug;8(4):389-99
1498695
EMBO J. 1994 Jun 15;13(12):2904-12
8026475
EMBO J. 1994 Jun 15;13(12):2913-24
8026476
Methods Mol Biol. 1997;74:275-9
9204442
J Mol Biol. 1999 May 21;288(5):911-40
10329189
Nucleic Acids Res. 2003 Jan 15;31(2):589-95
12527766
RNA. 1999 Nov;5(11):1458-69
10580474
J Biomol Struct Dyn. 1999 Dec;17(3):581-95
10636092
Nucleic Acids Res. 2000 Mar 15;28(6):1340-7
10684928
EMBO J. 2000 Dec 15;19(24):6860-9
11118221
EMBO J. 2001 Dec 3;20(23):6877-88
11726523